SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform
Go back to SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform| Russell 2000 Low Beta ETF (NASDAQ: SLBT) | Delayed: 1.72 -0.15 (8.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.87 | 52 Week High | $53.95 | |||
| Open | $1.82 | 52 Week Low | $44.11 | |||
| Day High | $1.89 | P/E | N/A | |||
| Day Low | $1.71 | EPS | $0.00 | |||
| Volume | 60,448 | |||||
